Company intelligence / Profile preview

Meizler UCB Biopharma

Barueri, São Paulo, Brazil

Ownership: Private
Development stage: Other

Overview

Meizler operates as a commercial-stage biopharmaceutical company focused on biologics development and manufacturing. The company has expanded into biotechnology product manufacturing and development, with involvement in recombinant genetic product development through a joint venture with a European-Argentinean company[1]. As part of UCB's partnership, Meizler is involved in the development of cerolizumab for rheumatoid arthritis through Brazil's Partnerships for Productive Development (PDP) program[4].

Therapeutic areas: HematologyImmunologyEndocrinologyCardiovascularInfectious DiseasesOncologyOphthalmology
Modalities: Recombinant proteinMonoclonal antibodyBiologic
Industry: Biotech

Partnerships

UCB (51% majority stake holder)[9]European-Argentinean company (joint venture for recombinant genetic product development)[1]Activa-CRO[1]GP Pharm[1]Allium Medical (stent distribution agreement)[3]

Beyond the preview

Go deeper on Meizler UCB Biopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meizler UCB Biopharma.

Explore the full profile